Skip to content

Clinical trials

Hyperinsulinism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperinsulinism Country / region: United States Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20042
20051
20071
20081
20095
20101
20132
20151
20163
20172
20183
20192
20202
20211
20222
20235
20248
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting11
Terminated4
Withdrawn3
Active, not recruiting2
Available2
Unknown status2
Not yet recruiting1
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Columbia University10
Children's Hospital of Philadelphia6
Rezolute4
Diva De Leon3
Yale University3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Ali Chappell1
Ball State University1
Boston Medical Center1
Colorado State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperinsulinism56
Insulin Resistance23
Obesity15
Hypoglycemia14
Congenital Hyperinsulinism10
Diabetes Mellitus9
Diabetes Mellitus, Type 27
Glucose Metabolism Disorders7
Non-alcoholic Fatty Liver Disease7
Prediabetic State6

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.